document

42
CURRICULUM VITAE RICHARD F. MAYER, M.D. Department of Neurology University of Maryland School of Medicine Baltimore, Maryland 21201 Phone: (410) 328- 6484 FAX: (410) 328-5899 E-mail: [email protected] EDUCATION: B.S. St. Bonaventure College, New York, Magna Cum Laude 1950 M.D. University of Buffalo School of Medicine, Alpha Omega Alpha 1954 POSTGRADUATE TRAINING: Medical Internship, Boston City Hospital, Boston, Massachusetts 1954-1955 Fellow in Neurology, Mayo Clinic and Foundation, Rochester, Minnesota 1955-1956 Resident in Neurology, Massachusetts General Hospital, 1956- 1957 Boston, Massachusetts Assistant in Research, The National Hospital, Queen Square 1957-1958 London, England Resident in Neuropathology, Massachusetts General Hospital 1958- 1959 Boston, Massachusetts Research Fellow in Neurology, Harvard Neurological Unit 1960-1964 Boston City Hospital, Boston, Massachusetts Guest Worker - Laboratory of Neural Control, NINCDS (NIH) 1974- 1975 Sabbatical Period APPOINTMENTS: Teaching Fellow in Neurology, Harvard Medical School 1956- 1961 Instructor in Neurology, Harvard Medical School

Upload: larry-roberts

Post on 27-Mar-2016

213 views

Category:

Documents


0 download

DESCRIPTION

http://medschool.umaryland.edu/facultyresearchprofile/uploads/69e0204dfc2d4cf59fb3636be6329967.doc

TRANSCRIPT

CURRICULUM VITAE

RICHARD F. MAYER, M.D.Department of NeurologyUniversity of MarylandSchool of MedicineBaltimore, Maryland 21201Phone: (410) 328- 6484FAX: (410) 328-5899E-mail: [email protected]

EDUCATION:

B.S. St. Bonaventure College, New York, Magna Cum Laude 1950

M.D. University of Buffalo School of Medicine, Alpha Omega Alpha 1954

POSTGRADUATE TRAINING:

Medical Internship, Boston City Hospital, Boston, Massachusetts 1954-1955

Fellow in Neurology, Mayo Clinic and Foundation, Rochester, Minnesota1955-1956

Resident in Neurology, Massachusetts General Hospital, 1956-1957

Boston, Massachusetts

Assistant in Research, The National Hospital, Queen Square 1957-1958

London, England

Resident in Neuropathology, Massachusetts General Hospital 1958-1959

Boston, Massachusetts

Research Fellow in Neurology, Harvard Neurological Unit 1960-1964

Boston City Hospital, Boston, Massachusetts

Guest Worker - Laboratory of Neural Control, NINCDS (NIH) 1974-1975

Sabbatical Period

APPOINTMENTS:

Teaching Fellow in Neurology, Harvard Medical School 1956-1961Instructor in Neurology, Harvard Medical School 1961-1965

Associate in Neurology, Harvard Medical School 1965-1966

Associate Professor, Neurology, University of Maryland 1966-1968

School of Medicine, Baltimore, Maryland

Professor, Neurology, University of Maryland 1968-1997

School of Medicine, Baltimore, Maryland

Professor Emeritus, Department of Neurology 1997-present

School of Medicine, Baltimore, Maryland

Guest Worker - Laboratory of Neural Control, NINCDS (NIH) 1975-1976

Sabbatical

Guest Worker - Laboratory of Neural Control, NINCDS (NIH) 1976-1997

Visiting

MILITARY EXPERIENCE:

Neurologist, U.S. Naval Hospital, Chelsea, Massachusetts 1959-1960

HOSPITAL APPOINTMENTS:

Director of Electroencephalography Laboratory, Harvard 1964-1966

Neurological Unit, Boston City Hospital

Associate Visiting Physician for Neurology, Boston City Hospital 1964-1966

Director, EMG and Neuromuscular Laboratory, University of 1966-1997

Maryland Hospital, Baltimore

BOARD CERTIFICATION:

Certified by the American Board of Psychiatry and Neurology 1961in Neurology

MEMBERSHIPS:

American Neurological AssociationAmerican Academy of Neurology, FellowAmerican Electroencephalography SocietyNew York Academy of ScienceSociety for NeuroscienceAmerican Association for the Advancement of ScienceAssociation for Research in Nervous and Mental DisordersFellow, Royal Society of MedicineAmerican Association for NeuropathologistsMaryland Neurologic SocietyAlpha Omega Alpha Honorary Medical Society

NATIONAL ACTIVITIES:

Member, Medical Advisory Board, Charcot-Marie-Tooth Disorders 1990-present

Foundation

-2-

Member, Medical Advisory Board, Myasthenia Gravis Foundation, 1978-present

New York City

Editorial Reviews, Neurology, Journal of Nervous and Mental 1978-present

Disease, Muscle and Nerve, Archives of Neurology

Member, Research Site Review, NINCDS 1976-1997

S. Wier Mitchell, Research Award Committee, American 1977-1979

Academy of Neurology

Member, Neurobiology Merit Review Board, Veterans Administration 1979-1982

Examiner, American Boards of Neurology and Neurosurgery 1968-1997

MAJOR RESPONSIBILITIES:

School of Medicine and Hospital

Professor of Neurology, Acting Chairman 1977-1981

Director, Neurology Resident Training Program 1977-1981

Director, EMG and Nerve Conduction Laboratories, Neuromuscular 1966-1993

and Myasthenia Gravis Clinics, University of MarylandHospital

Director, EMG - Neuromuscular Laboratory 1966-1997

TEACHING/COMMITTEE ACTIVITIES:

Neuroscience Courses I and II - lecture demonstrationNeurological Aspects of Physical Diagnosis - first and second year classesLecture, Demonstrations in Neurology - third year clerkships in NeurologyAttending Ward Neurologist and Consultations (1966-1996)Neuromuscular Clinic and Rounds, EMG ConferenceSeminars in Neuromuscular Disease and Clinical Neurophysiology, Post-graduate and studentsClinical Conferences in Neurology and Neuropathology - PG trainees in Neurology and studentsMember, Medical School Council (1994-1997)Member, Executive Committee, Department of Neurology (1990-1997)

RESEARCH ACTIVITIES:

Peripheral Neuropathy: Clinical Physiological, Morphological, Therapeutic and Immunological Studies (Dr. C.L. Koski).

Myasthenia Gravis: Clinical, Immunological and Therapeutic.

Therapeutic and Physiological Studies in Motor Neuron Disease and Motor Neuronopathies.

-3-

PUBLICATIONS:

1. Mayer RF: Nerve conduction studies in man. Neurology (Minneap.) 13:1021-2030, 1963.

2. Eiken O, Nabseth DC, Mayer RF, and Deterling RA, Jr.: Limb replantation. I. The techniques and immediate results. Arch. Surg. 88:48-53, 1964.

3. Eiken O, Nabseth DC, Mayer RF, and Deterling RA, Jr.: Limb replantation. II. The pathophysiological effects. Arch. Surg. 88:54-65, 1964.

4. Eiken O, Mayer RF, Nabseth DC, Apostolou K, and Deterling RA, Jr: Limb replantation. III. Long-term evaluation. Arch. Surg. 88:66-77, 1964.

5. Mayer RF, Eiken O, and Nabseth DC: Nerve regeneration in replanted canine limbs. Am. J. Physiol. 206:1415-1421, 1964.

6. Mayer RF and Denny-Brown D: Conduction velocity in peripheral nerve during experimental demyelination in the cat. Neurology (Minneap.) 14:714-716, 1964.

7. Mawdsley C and Mayer RF: Nerve conduction in alcoholic polyneuropathy. Brain 88:335-356, 1964.

8. Mayer RF and Mawdsley C: Studies in man and cat of the significance of the H wave. J Neurol Neurosurg Psychiat 28:201-211, 1965.

9. Mayer RF: Peripheral nerve function in vitamin B12 deficiency. Arch. Neurol. 13:355-362, 1965.

10. Mayer RF: Peripheral nerve conduction in alcoholics. Studies of the effects of acute and chronic intoxication. Psychmat. Med. 28:475-483, 1966.

11. Juul-Jensen P and Mayer RF: Threshold stimulation for nerve conduction studies in man. Arch. Neurol. 15:410-419, 1966.

12. Mayer RF and Feldman RF: Observations on the nature of the F wave in man. Neurology (Minneap) 17:147-156, 1967.

13. Doyle AM and Mayer RF: Studies of the motor unit in the cat. A preliminary report. Bull. Sch. of Med. University of Maryland, 54:11-17, 1969.

14. Mayer RF and Mosser RS: Excitability of motor neurons in infants. Neurology 19:932-945, 1969.

15. Feldman RF, Mayer RF, and Taub AA: Evidence of peripheral neurotoxic effect of trichlorethylene. Neurology 20:599-606, 1970.

16. Mayer RF: Conduction velocity in the central nervous system of the cat during experimental demyelination and remyelination. Internat. J. Neurosci. 1:287-308, 1971.

17. Max SR, Mayer RF, and Vogelsang L: Lysosomes and disuse atrophy of skeletal muscle. Arch. Biochem. Biophys. 146:227-232, 1971.

18. Garcia-Mullin R and Mayer RF: H reflexes in acute and chronic hemiplegia. Brain 95:559-572, 1972.

19. Garcia-Mullin R and Mayer RF: Associated motor unit activity in hemiplegia.

Electromyography and Clin. Neurophysiol. (Belgium) 12:5-18, 1972.

-4-

20. Wexler I and Mayer RF: Temperature sensitivity of slowly adapting mechanoreceptors. Brain Res. 59:384-388, 1973.

21. Mayer RF and Williams IR: Incrementing responses in myasthenia gravis. Arch. Neurol. (Chic.) 31:24-26, 1974.

22. Albuquerque EX, Almon R, Appel SH, Kauffman FC, Lebeda FJ, Mayer RF, Narashashi T, and Yeg JZ: Effects of myasthenia serum factors in normal and chronically denervated mammalian muscles. Ann. NY Acad. Sci. 274:475-492, 1976.

23. Williams IR and Mayer RF: Subacute proximal diabetic neuropathy. Neurology 26:108-116, 1976.

24. Albuquerque EX, Rash JE, Mayer RF, and Satterfield JR: An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis. Exp. Neurol. 51:536-563, 1976.

25. Rash JE, Albuquerque EX, Hudson CS, Mayer RF, and Satterfield JR: Studies in human myasthenia gravis; electrophysiological and ultrastructural evidence compatible with antibody attachment to the acetylcholine receptor complex. Proc. Nat. Acad. Sci. 73 (No. 12): 4584-4588, December, 1976.

26. Huang S-W, Rose JW, and Mayer RF: Assessment of cellular and humoral immunity of myasthenics. J. Neurol. Neurosurg. Psychiat. 40: 1053-1059, 1977.

27. Mayer RF: Structure and function of the motor unit; effects of immobilization, monoparesis or paraplegia. Electroenceph. Clin. Neurophysiol. Suppl. 34: 479-485, 1978.

28. Stein C, Moore W, Weinrich D, and Mayer RF: Choline levels in plasma of myasthenia gravis patients and normal individuals. Ann. Neurol. 4:209-291, 1978.

29. Mano Y, Mano K, Mayer RF, Deshpande SS, and Albuquerque EX: The effects of paraplegia produced by intrathecal 6-aminonicotinamide on motor units in the rat. Exp. Neurol. 65:435-456, 1979.

30. Mayer RF, Burke RE, Hodgson JA, Kanda K, Toop J, and Walmsley B: The effects of long-term immobilization on the motor unit population of the cat medial gastrocnemius muscle. Neuroscience 6:725-739, 1981.

31. Rash JE, Hudson CS, Graham WF, Mayer RF, Warnich JE, and Albuquerque EX: Freeze-fracture studies of human neuromuscular junctions; Membrane alterations observed in myasthenia gravis. Lab. Investigation 44:519-530, 1981.

32. Max SR, Young JL, and Mayer RF: Neural regulation of glucose 6-phosphate dehydrogenase in rat muscle. Effects of denervation and reinnervation. Brain Res. 220:131-138, 1981.

33. Huang S-W, Yang J, Mayer RF, and Mouton A: Thymocytes and serum antibodies of nucleic acids in myasthenia gravis. Ann. NY Acad. Sci. 337:833-834, 1981.

34. Rash JE, Hudson CS, Albuquerque EX, Eldefrawi ME, Mayer RF, Graham WF, Johnson TJA, and Giddings FD: Freeze-fracture, labeled-replica and electrophysiological studies of junction fold destruction in myasthenia gravis and experimental autoimmune myasthenia gravis. Ann. NY Acad. Sci. 377:38-60, 1981.

35. Albuquerque EX, Warnick JE, Mayer RF, Eldefrawi AE, and Eldefrawi ME: Recent advances in the molecular mechanisms of human and animal models in myasthenia gravis. Ann. NT Acad. Sci. 337:496-518, 1981.

-5-

36. Young JL and Mayer RF: Physiological alterations of motor units in hemiplegia. J. Neuro. Sci. 54:401-412, 1982.

37. Mayer RF and Peters R: Diabetic neuropathy. Medical Grand Rounds 2:274-283, 1983.

38. Mayer RF: Neuromuscular transmission in single motor units in myasthenia gravis. Muscle and Nerve 5:S46-S49, 1982.

39. Mayer RF, Burke RE, Toop J, Walmsley B,and Hodgson JA: The effects of spinal cord transection on motor units in the cat medial gastrocnemius muscles. Muscle and Nerve 7:23-31, 1984.

40. Yeagle SP, Mayer RF, and Max SR: Contractile properties of fast-twitch skeletal muscles of normal testosterone-treated and castrated rats during reinnervation. Exp. Neurol. 82:344-357, 1983.

41. Salcman M and Mayer RF: Intramedullary subependymoma of the cervical cord: Case report. Neurosurgery 14:608-611, 1984.

42. Sellman MS and Mayer RF: Weakness and tiredness: When to suspect myasthenia gravis. Geriatrics 40:92-112, 1985.

43. Sellman MS and Mayer RF: Treatment of myasthenic crisis in late life. Southern Medical Journal 78:1208-1210, 1985.

44. Hankins JR, Mayer RF, and Sutterfield JR et al: Thymectomy for myasthenia gravis: 14-year experience. Ann. Surg. 201:618-625, 1985.

45. Bernard PA, Toyoshima E, Eccles CU, Mayer RF, Johnson KP, and Max SR: 2,4-dichlorophenoxyacetic acid (2,4-D) reduces acetylcholinesterase activity in rat muscle. Exp. Neurol. 87:544-556, 1985.

46. Toyoshima E, Mayer RF, Max SR, and Eccles C: 2,4-dichlorophenoxyacetic acid (2,4-D) does not cause polyneuropathy in the rat. J. Neurol. Sci. 70:225-229, 1985.

47. Koski CL, Gratz E, Sutherland J, and Mayer RF: Clinical correlation with anti-peripheral myelin antibodies in Guillain-Barre syndrome. Ann. Neurol. 19:573-577, 1986.

48. Toyoshima E, Mayer RF, and Max SR: The effects of 2,4-dichlorophenoxyacetic acid (2,4-D) on the contractile properties of reinnervated rat skeletal muscle. Exp. Neurol. 90:601-610, 1985.

49. Lee RE, Poulos AC, Mayer RF, and Rash JE: Caveolae preservation in the characterization of human neuromuscular disease. Muscle and Nerve 9:127-137, 1986.

50. Toyoshima E, Yeager AM, Brennan S, Santos GW, Moser HW, and Mayer RF: Nerve conduction studies in the Twitcher mouse (murine globoid cell leukodystrophy). J. Neurol. Sci. 74:307-318, 1986.

51. Sellman MS and Mayer RF: Conduction block in hereditary neuropathy with susceptibility to pressure palsies. Muscle and Nerve 10:621-625, 1987.

52. Toyoshima E, Mano Y, Ando K, Ishihara T, Miyazaki S, Yamashita Y, and Mayer RF: Recording and analysis of gait foot-forces using telemetric force-transducers

in patients with Duchenne muscular dystrophy. Electromyogr. Clin. Neurophysiol. 27:355-361, 1987.

-6-

53. Toyoshima E, Tomi H, Mano Y, Ando K, and Mayer RF: Kinesiometric analysis of motor dysfunction in patients with subacute myelo-optico neuropathy (SMON). Electromyogr. Clin. Neurophysiol. 27:361-369, 1987.

54. Sellman MS and Mayer RF: Thoraco-abdominal radiculopathy. South Med. J. 81:199-201, 1988.

55. Khurana RK, Koski CL, and Mayer RF: Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. J. Neurol. Sci. 85:77-86, 1988.

56. Hsueh I-H, Toyoshima E, and Mayer RF: The effects of 4-aminopyridine on focal nerve conduction block. Restorative Neurol. and Neurosci. 1:39-46, 1989.

57. Rudnicki S, Vriesendorp F, Koski CL, and Mayer RF: Electrophysiologic studies in the Guillain-Barre syndrome. Effects of plasma exchange and antibody rebound. Muscle and Nerve 15:57-62, 1992.

58. Vriesendorp F, Mayer RF, and Koski CL: Kinetics of anti-peripheral nerve myelin antibody in plasmapheresed and non-plasmapheresed patients with Guillain-Barre Syndrome. Arch. Neurol. 48:858-861, 1991.

59. Mano Y, Nakamuro T, Ikoma K, Takayanagi T, and Mayer RF: A clinicophysiologic study of central and peripheral motor conduction in hereditary demyelinating motor and sensory neuropathy. Electromyography and Clinical Neurophysiology, 33:101-107,1993.

60. Good JL, Khurana RK, Mayer RF, Cintra WM, and Albuquerque EX: Pathophysiologic studies of neuromuscular function in subacute organophosphate poisoning induced by phosmet. J. Neurol. Neurosurg. Psychiat. 56:290-294, 1993.

61. Mano Y, Nakamuro T, Takayanagi T, and Mayer RF: Ceruletide therapy in action tremor following thalamic hemorrhage. J. Neurol. 240:144-148, 1993.

62. Wilensky R, Dwyer B, and Mayer RF: Relapses in patients with myasthenia gravis treated with azathioprine. Ann. N.Y. Acad. Sci. 681:591-594, 1993.

63. Mayer RF: Myasthenia gravis and diseases of the neuromuscular junction. Acta Neurol. Sin., 2:9-26, 1993.

64. Mayer, RF: Advances in the therapy of neuromuscular disease. Neurological Therapeutics (Jap) 10:533-543, 1993.

65. Vriesendorp FJ, Triggs WJ, Mayer RF, and Koski CL: Electrophysiological studies in Guillain-Barre syndrome; correlation with antibodies to GM1, GD1B, and campylobacter jejuni. J. Neurol. 242:460-465, 1995.

66. The Diabetes Control and Complications Trial Research Group: The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:977-986, 1993.

67. Mano Y, Morita Y, Tamura R, Morimoto S, Takayanagi T, and Mayer RF: The site of action of magnetic stimulation of human motor cortex in a patient with motor neuron disease. J. Electromyograph. Kinesiol. 3:245-250, 1993.

-7-

68. Mano Y, Nakamuro T, Tamura R, Takayanagi T, Kawanishi K, Tamai S, and Mayer RF: Central motor reorganization after anastomosis of the musculocutaneous and intercostal nerves following cervical root avulsion. Ann. Neurol. 38:15-20m 1995.

69. Weiss MD and Mayer RF: Temperature sensitive repetitive discharges in paramyotonia congenita. Muscle and Nerve 20:195-197, 1997.

70. Khurana RK and Mayer RF: Painful trigeminal neuropathy; clinical and pharmacological observations. Headache 37:522-526, 1997.

71. Good JL, Chehrenama M, Mayer RF, and Koski CL: Pulse Cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 51:1735-1738, 1998.

72. Mayer RF: The motor unit and electromyography. The Legacy of Derek Denny-Brown. J. Neurol. Sci. 189:7-11, 2001.

73. F-FWu, A. Ryan, J. Devaney, M. Warnsteat, Z. Korade-Mirnics, B. Poser, M.J. Escriva, E. Pegoraro, A.S.

Yee, K. J. Felice, M.J. Giuliani, R.F. Mayer, T. Mongini, L. Palmucci, M. Marino, R. Riidel, E.P. Hoffman, and C. Fahlke. Novel CLCN1 Mutations with Unique Clinical and Electrophysiological Consequences. Brain 125:2392-2407, 2002.

CHAPTERS

1. Nabseth DC, Mayer RF, and Deterling RA, Jr: Experimental basis of limb replantation. In: Advances in Surgery, Vol 2, C Welch, ed., Year Book Med. Pub. Inc., Chicago, 1966, pp. 35-37.

2. Mayer RF: The neuromuscular defect in human botulism. In: Modern Neurology; Papers in Tribute to Derek Denny Brown. S Locke, ed., Little, Brown & Co., Boston, pp. 169-186, 1969.

3. Mayer RF and Garcia-Mullin R: Peripheral nerve and muscle disorders associated with alcoholism. In: The Biology of Alcoholism, Vol. II, B Kissin and H Begleiter, eds., Plenum Publ. Copd., New York, pp. 21-65, 1972.

4. Mayer RF: Hereditary neuropathy manifested by recurrent palsies. In: Handbook of Clinical Neurology, Vol. 21, Chap. 4, PJ Vinken and GW Bruyn, eds., North-Holland Publ. Co., Amsterdam, pp. 970-1005, 1975.

5. Mayer RF and Koski CL: Treatment of acute respiratory muscle failure. In: Neurologic Emergencies, M Salcman, ed., Raven Press, 1980. Chapt. 12, pp 181-206.

6. Young JL and Mayer RF: Physiologic Properties and classification of motor units activated by microstimulation in the first dorsal interosseous muscle in man. In: Progress in Clinical Neurophysiology, Vol. 9, JE Desmedt, ed., Karger, Basel, 1981, pp 17-25.

7. Mayer RF and Khurana RK: Peripheral and autonomic nervous system. In: Encyclopedic Handbook of Alcoholism, EM Patterson and E Kaufman, eds., Section III, Chapter 13, Gardner Press, New York, 1982, pp 194-203.

8. Mayer RF and Max SR: Denervation and reinnervation of skeletal muscle: Physiological and biochemical aspects. In: Myasthenia Gravis, EX Albuquerque and AT Eldefrawi, eds., Chapman and Hall, Ltd., London, 1983, pp 215-246.

9. Max SR and Mayer RF: Physiological and biochemical aspects of skeletal muscle denervation and reinnervation. In: Peripheral Neuropathy, 2nd Ed, PJ Dyck, PK Thomas, EH Lambert, and R Bunge, eds., Saunders, Philadelphia, 1984, pp 400-409.

-8-

10. Mayer RF, Burke RE, Toop J, Walmsley B, and Hodgson JA: The effect of spinal cord lesions on motor units in cat medial gastrocnemius muscle. In: Recent Achievements in Restorative Neurology, Sir J Eccles and MR Dimitrijevic, eds., S Karger, Basel, 1985, pp 136-149.

11. Mayer RF: An outline for the evaluation of neuromuscular disease, Diseases of the neuromuscular junction, Genetic aspects of neuromuscular diseases. In: Syllabus, Neuromuscular Diseases, JH Petajan, ed., Veterans Administration, Washington, DC, 1985.

12. Mayer RF, Koski CL, and Max SR: Restorative neurology in myasthenia gravis and disorders of peripheral nerve and muscle. In: Recent Achievements in Restorative Neurology 2; Progressive Neuromuscular Diseases, M. Dimitrijevic, B Kakulas, and G Vrbova, eds., S Karger, Basel, 1986, pp 184-202.

13. Koski CL, Khurana R, and Mayer RF: Guillain-Barre syndrome. In: American Family Physician, 34:198-210, 1986.

14. Mayer RF and Potes E: Biological toxins. In: Current Therapy in Neurologic Diseases, 2nd Ed., RT Johnson, eds., BC Decker, 1987, pp 270-274.

15. Cherry S and Mayer RF: Hereditary neuropathy with liability to pressure palsies. In: Handbook of Clinical Neurology, Vol. 7, WB Matthews, Ed., Elsevier Science Publishers, Amsterdam, 1987, pp 551-562.

16. Potes E and Mayer RF: Treatment of respiratory muscle failure. In: Neurologic Emergencies, 2nd Ed., M Salcman, ed., Raven Press, New York City, 1990, pp 218-305.

17. Mayer RF, Rudnicki S, and Sellman MS: Muscle contractile properties in dominantly inherited demyelinating polyneuropathy. In: Charcot-Marie-Tooth Disorders, RE Lovelace and HK Shapiro, eds., Wiley Liss, New York City, 1990, pp 125-131.

RESEARCH SEMINARS - SHORT ARTICLES

1. Mayer RF: Observations on some mechanisms of altered nerve conduction in man. Proc. 8th Int. EEG Cong. Neurol., Vienna, II:423-427, 1965.

2. Mayer RF and Mawdsley C: Parameters of the H wave in pathological states. Proc. 6th Int. Cong. EEG Clin. Neurophysiol., Vienna, 635-638, 1965.

3. Mayer RF: Conduction velocity in spinal cord during experimental demyelination in the cat. Trans. Am. Neurol. Assoc. 91:294-296, 1966.

4. Mayer RF and Mosser RS: Vestibular effects on monosynaptic (H) reflexes. Trans. Am. Neurol. Assoc. 92:269-270, 1967.

5. Mayer RF: The effect of demyelination on conduction in cat spinal cord. Proc. 2nd Pan American Congress of Neurology, San Juan, Puerto Rico, pp 408-419, 1967.

6. Mayer RF and Garcia-Mullin R: Hereditary Neuropathy manifested by pressure palsies. A Schwann cell disorder? Trans. Am. Neurol. Assoc. 93:238-240, 1968.

7. Mayer RF and Doyle AM: Studies of the motor unit in the cat. Histochemistry and topology of anterior tibial and extensor digitorum longus muscles. In: Muscle Diseases, JN Walter, N Canal, G Scarlato, eds., Excerpta Medica, Amsterdam, pp 159-163, 1970.

8. Mayer RF and Doyle AM: The motor unit potential and its relation to the motor unit. Trans. Amer. Neurol. Assoc. 95:282-283, 1970.

-9-

9. Mayer RF and Mosser RS: Maturation and human reflexes. Studies of electrically evoked reflexes in newborns, infants, and children. In: New Developments in Electromyography and Clinical Neurophysiology, JE Desmedt, ed., Vol 1, Karger, Basel, pp 294-307, 1973.

10. Mayer RF: The motor unit. Discussions and observations in cat anterior tibial muscle. In: New Developments in Electromyography and Clinical Neurophysiology, JE Desmedt, ed., Vol 1, Karger, Basel, pp 31-34, 1973.

11. Mayer RF: Recent studies in man and animals of peripheral nerve and muscle dysfunction associated with chronic alcoholism. In: Alcoholism and the Central Nervous System, FA Seixas and S Egglestein, eds., Ann. NY Acad. Sci. 215:370-372, 1973.

12. Max SR and Mayer RF: Mitochondria and muscle disease. Trans. Amer. Neurol. Assoc. 97:306-307, 1972.

13. Mayer RF, Williams IF, and Snyder DH: Variability of neuromuscular transmission in myasthenia gravis. Trans. Amer. Neurol. Assoc. 98:83-86, 1973.

14. Mayer RF: L-dopa, Parkinsonism and involuntary movements. Trans. Amer. Neurol. Assoc. 99:163-166, 1974.

15. Rose JW, Huang S-W, and Mayer RF: Immunological studies in myasthenia gravis. Trans. Amer. Neurol. Assoc. 100:60-63, 1975.

16. Mayer RF: L-dopa induced involuntary movements in Parkinsonism. F wave studies. In: Advances in Parkinsonism, W Birkmeyer and O Hornykiewicz, eds., Editons Roche, Basel, pp 591-595, 1976.

17. Mayer RF, Burke RE, and Kanda K: Immobilization and muscle atrophy. Trans. Amer. Neurol. Assoc. 101:145-150, 1976.

18. Mayer RF, Mano Y, and Albuquerque EX: Physiological and histochemical changes in skeletal muscle of rats rendered paraplegic by 6-aminonicotinamide. Presented at the Massachusetts General Hospital Scientific Symposium in honor of Dr. RD Adams, May 19-20, 1977.

19. Mayer RF, Albuquerque EX, Rash JE, and Hudson CS: Neuromuscular junction and myasthenic crisis. Trans. Amer. Neurol. Assoc. 102:100-104, 1977.

20. Mayer RF and Young JL: The effects of hemiplegia with spasticity on single motor units. In: Spasticity; Disordered Motor Control. R Feldman, R Young, and WP Koella, eds., Year Boo, Med. Publ., Chicago, pp 133-146, 1979.

21. Mayer RF and Young JL: Physiological properties of muscle units in man. Trans. Amer. Neurol. Assoc. 104:193-196, 1979.

22. Mayer RF: Peripheral nerve conduction and toxic effects on the motor unit. Electroenceph. Clin. Neurophysiol. Suppl. 36:701-708, 1982.

23. Mayer RF: Living with ALS. Archives of the Foundation of Thanatology, New York City, 1988.

24. Dwyer BA, Mayer RF, and Lee SC: Progressive nemaline (rod) myopathy as a presentation of HIV infection. Arch. Neurol. 49:440, 1992.

-10-

25. Tamura R, Mano Y, Takayanagi T, and Mayer RF: 3,4-Diaminopyridine in demyelinating peripheral neuropathies. Ann. Neurol. 36:454, 1994.

26. Mano Y, Takayanagi T, and Mayer RF: Cortical mapping of skeletal muscles of motor neuron disease. In: Recent Advances in Clinical Neurophysiology, J Kimura and H Shibasaki, eds., Elsevier, Amsterdam, pp 340-343, 1996.

27. Mayer RF: The motor unit, electromyography and neuromuscular disease. In: Recent Advances in Clinical Neurophysiology, J Kimura and H Shibasaki, eds., Elsevier, Amsterdam, pp 370-372, 1996.

28. Mano Y, Chuma T, Morimotor S, Takayanagi T, and Mayer RF: Motor reorganization in central and peripheral nervous system disorders. In: Recent Advances in Clinical Neurophysiology, J Kimura and H Shibasaki, eds., Elsevier, Amsterdam, pp 970-973, 1966.

29. Mayer RF and Skopets IA: Inclusion body myositis and rimmed vacuole myopathies. Neuroimmunology (Jap) 5:20-21, 1997.

30. Mayer RF and Bergey GK: Early American professorships in neurology. Ann. Neurol. 41:416-417, 1997.

ABSTRACTS - 1980-present

1. Mayer RF, Burke RE, Toop J, Walmsley B, Hodgson J, and Kanda K: Atrophy of cat medial gastrocnemius muscle in chronic paraplegia is different from that in immobilization. Neurology (Abstr.) 30, 414, 1980.

2. Huang SW, Yang J, and Mayer RF: Thymocytyes and serum antibody to nucleic acids. International Conference on Myasthenia Gravis, New York Academy of Science, Dec. 3, 1980.

3. Mayer RF, Max SR, and Young JL: Muscle reinnervation: Correlation of glucose 6-phosphate dehydrogenase activity and twitch tension. Neurology (Abstr.) 32(2):46, 1981.

4. Mayer RF: Peripheral nerve conduction and toxic effects on the motor unit. 10th Inst. Cong. EEG and Clin. Neurophysiol., Kyoto, Japan, Sept. 16, 1981.

5. Kauffman FC, Mayer RF, Daly JW, and Albuquerque EX: Ca++ activated ATPase in human muscular dystrophies; resistance to pumiliotoxin. Neurology 32:A200-A201, 1982.

6. Mayer RF: Neuromuscular transmission in single motor units in myasthenia gravis, EH Lambert Symposium, Rochester, Minn., April 24, 1982, Abstract No. PT10.

7. Mayer RF, Young JL, Yeagle SP, and Max SR: Physiological and biochemical studies of muscle reinnervation. Vth Int. Congr. Neuromuscular Diseases, Marseilles, France, Sept. 12, 1982, Abstract No. 37.3.

8. Yeagle SP, Mayer RF, and Max SR: Contractile properties of skeletal muscle undergoing reinnervation. Effects of testosterone and castration. Soc. Neurosci. Abstr. 8:859, 1982.

9. Yeagle SP, Mayer RF, and Max SR: Post-tetanic potentiation in reinnervated skeletal muscle. Neurology 33 (Suppl. 2):119, 1983. Presented at the Annual Meeting of the American Academy of Neurology, San Diego, CA, April 28, 1983.

10. Sellman MS and Mayer RF: Treatment of myasthenic crisis in late life. Southern Med. Assoc., Annual Meeting, Nov. 7, 1983, Baltimore, MD.

-11-

11. Cherry S, Dave P, and Mayer RF: Hereditary motor neuropathy with bilateral hemiplegic distribution. Am. Neurol. Assoc. 1983. Presented October 3, 1983, New Orleans, LA, Ann. Neurol. 14:119-120, 1983.

12. Khurana R, Koski CL, and Mayer RF: Dysautonomia in Eaton-Lambert syndrome. Am. Neurol. Assoc. 1983. Presented October 3, 1983, New Orleans, LA, Ann. Neurol. 14:123, 1983.

13. Mayer RF and Toyoshima E: The effect of motor activity on the contractile properties of human motor units. VIIth Int. Cong. EMG, Munich, Germany, 1983. Electroenceph. Clin. Neurophysiol. 56:S131-132, 1983.

14. Yeagle SP, Mayer RF, and Max SR: Contractile properties of fast-twitch muscle during reinnervation in the rat. VII Int. EMG Cong., Munich, Germany, October 9-13, 1983. Electroenceph. Clin. Neurophysiol. 56:S201, 1983.

15. Bernard PA, Toyoshima E, Eccles CU, Mayer RF, Johnson KP, and Max SR: Acute effects of 2,4-dichlorophenoxyacetic acid (2,4-D) in neuromuscular function in rats. Soc. Neurosci. Abs. 9:423, 1983.

16. Albuquerque EX, Akaiki A, Rickett D, and Mayer RF: Pyridostigmine interacts with the nicotine acetylcholine receptor-ionic channel complex. Ann. Sci. Meet. Myasthenia Gravis Foundation, December 2, 1983, New York, NY.

17. Toyoshima E, Mayer RF, and Max SR: Does 2,4-dichlorophenoxyacetic acid (2,4-D) cause polyneuropathy? Presented at the American Academy of Neurology, Boston, MA, April 10, 1984; Neurology, 34 (Suppl. 1):145, 1984.

18. Albuquerque EX, Akaiki A, Rickett D, and Mayer RF: Pyridostigmine interacts with the nicotonic acetylcholine receptor-ionic channel complex. Presented at Am. Neurol. Assoc., Baltimore, October 9, 1984; Am. Neurol. 16:146, 1984.

19. Koski CL, Cherry S, and Mayer RF: Correlation of anti-peripheral myelin antibody kinetics with clinical course in Guillain-Barre syndrome. Ann. Neurol. 16:112-113, 1984.

20. Toyoshima E, Tomi H, Mano Y, Ando K, and Mayer RF: Kinesiometric analysis of the motor dysfunction of patients with subacute myelo-optico neuropathy (SMON) and patients with other neurologic disorders. Soc. Neurosci., 14th Ann. Meeting, Anaheim, CA Soc. Neurosci. Abstr. 10(1):636, 1984.

21. Mayer RF, Toyoshima E, and Max SR: The effects of 2,4-dichlorophenoxyacetic acid (2,4-D) on the contractile properties of reinnervated rat muscle. Soc. Neurosci. Abstr. 10(2):1193, 1984.

22. Sellman MS and Mayer RF: Physiologic changes in motor units of patients with hereditary hypertrophic polyneuropathy. Am. Assoc. Electromyography & Electrodiagnosis, Kansas City, Missouri, September 21, 1984. Muscle & Nerve 7:568, 1984.

23. Mayer RF: Restorative neurology: Myasthenia gravis and disorders of peripheral nerve and muscle. Presented at Recent Achievements in Restorative Neurology, Houston, TX, October 11-13, 1984.

24. Hankins JR, Mayer RF, Satterfield JR,et al:Thymectomy for myasthenia gravis:14-year experience. 96th South Surg Assoc. Palm Beach, FL, Dec 3-5, 1984.25. Toyoshima E, Mayer RF, Yeager AM, and Moser HW: Nerve conduction studies in the twitcher mouse. AAN Meeting, Dallas, TX, May, 1985, Neurology, 35 (Suppl.

1):76, 1985.

-12-

26. Mayer RF, Toyoshima E, Yeager AM, and Moser HW: The pathophysiology of peripheral neuropathy in mouse (Twitcher) globoid cell leukodystrophy. 11th Int. Cong. EEG and Clin. Neurophysiol., London, England, August, 1985, Electroenceph. Clin. Neurophysil. 61:S20, 1985.

27. Mayer RF, Toyoshima E, Potes E, Yeager AM, and Moser HW: Histochemistry of gastrocnemius muscles in the twitcher mouse. Soc. Neurosci. Abstr. 15:213, 1985.

28. Yeager AM, Toyoshima E, Mayer RF, Brennan S, Moser HW, and Santos GW: Hematopoietic cell transplantation (HCT) in murine globoid cell leukodystrophy (GCL): clinical and electrophysiologic studies. The American Society of Hematology, Blood, 66 (Suppl. 1):256a, 1985.

29. Sellman MS, Cherry S, and Mayer RF: Conduction block in hereditary neuropathy with susceptibility to pressure palsies (tomaculous neuropathy). Presented at the Annual Meeting of the Am. Assoc. EMG and Electrodiag., Las Vegas, NV, October 25-26, 1985, Muscle & Nerve 8:625, 1985.

30. Mayer RF, Steers J, and Potes E: Prevention and treatment of myasthenic crisis in patients over 50. NY Acad. Sci. 7th Int. Conf. Myasthenia Gravis, Abstracts, p 89, New York City, March 4-7, 1986.

31. Huang S-W, Agarwal S, Eldefrawi ME, and Mayer RF: Hybridoma cell lines developed from myasthenia thymus. NY Acad. Sci. 7th Int. Conf. Myasthenia Gravis, Abstracts, p 19, New York City, March 4-7, 1986.

32. Toyoshima E, Potes E, Yeager AM, Brennan S, Moser HM, and Mayer RF: The effects of demyelinating neuropathy on the soleus muscle in hematopoietic cell transplantation of the Twitcher mouse (Murine Globoid Cell Leukodystrophy). AAN Meeting, New Orleans, May 1, 1986. Neurology, 36 (Suppl. 1):301, 1986.

33. Potes E, Cherry S, Hoffman PM, and Mayer RF: Therapeutic trials in amyotrophic lateral sclerosis. VIth Int. Cong. Neuromuscular Disease, Los Angeles, CA, July 6-11, 1986. Muscle & Nerve, 9(5S):106, 1986.

34. Toyoshima E, Potes E, Yeager AM, Moser HM, and Mayer RF: The effects of hematopoietic cell transplantation (HCT) in the demyelinating neuropathy in the Twitcher mouse. VIth Int. Cong. Neuromuscular Disease, Los Angeles, CA, July 6-11, 1986. Muscle & Nerve 9(5S):140, 1986.

35. Potes E, Toyoshima E, Mayer RF, and Koski CL: Conduction block by serum from patients with Guillain-Barre syndrome (GBS). VIth Int. Cong. Neuromuscular Disease, Los Angeles, CA, July 6-11, 1986. Muscle & Nerve 9(5S):138, 1986.

36. Toyoshima E, Yeager AM, Moser HW, and Mayer RF: The effects of chronic demyelinating neuropathy on the soleus muscle of the Twitcher mouse. Peripheral Neuropathy Association of America, November 4-8, 1986.

37. Mayer RF, Potes E, Yeager AM, Moser HW, and Toyoshima E: Contractile properties of hind limb muscles in the demyelinating neuropathy of the Twitcher mouse. Soc. Neurosci. Abstr., 12, Part 2, 1085, 1986.

38. Sellman MS and Mayer RF: Thoraco-abdominal radiculopathy. Southern Medical Association, Atlanta, GA, November 8, 1986, South Med. J., 79:215, 1986.

39. Dawson RB, Mayer RF, Ulsch C, Greber R, and Anthony M: The therapeutic hemapheresis: Additional evidence for a smooth muscle defect in myasthenia

gravis. Clinical Res., 34:873A, 1986.

40. Hsueh I-H, Toyoshima E, and Mayer RF: Does 4-aminopyridine reverse conduction block? Neurology, 37(Suppl. 1):363, 1987.

-13-

41. Mayer RF, Hsueh I-H, Toyoshima E: The effects of 4-aminopyridine on focal nerve conduction block. Electroenceph. Clin. Neurophysiol. 66:S66, 1987.

42. Mayer RF, Rudnicki S, and Sellman MS: Muscle contractile properties in dominantly inherited demyelinating polyneuropathy. Proc. Second International Conference on Charcot-Marie-Tooth Disorders, Columbia University, June 28 - July 1, 1987, p 10.

43. Hsueh I-H, Rudnicki S, and Mayer RF: The effects of psychosine on normal and demyelinated peripheral nerve. Neurology 38 (Suppl. 1):401, 1988.

44. Mayer RF and Hsueh I-H: Treatment of tellurium induced nerve conduction block with 4-aminopyridine (4-AP). Peripheral Neuropathy Association of America, Abstracts, page 35, Halifax, Nova Scotia, July 20, 1988.

45. Rudnicki S, Mayer RF, and Koski CL: Electrophysiological correlations with anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome. Ann. Neurol. 24:163, 1988.

46. Mayer RF, Hsueh I-H, and Rudnicki S: The effects of intraneural psychosine on peripheral nerve. Ann. Neurol. 24:481, 1988.

47. Rudnicki S, Mayer RF, and Koski CL: Serial peripheral nerve conduction studies and anti-peripheral nerve myelin antibodies in acute and prolonged Guillain-Barre syndrome. Muscle & Nerve, 11:962, 1988.

48. Vriesendorp FJ, Rudnicki S, Mayer RF, and Koski CL: Plasma exchange and antibody rebound in the Guillain-Barre syndrome (GBS). Neurology 39 (Suppl. 1):291, 1989.

49. Albuquerque EX, Good JL, Khurana R, and Mayer RF: Organophosphate (Phosmet) induced degeneration of neuromuscular junction in man. Myasthenia Gravis Medical Advisory Board Meeting, New York City, December 1, 1989.

50. Good JL, Khurana R, Mayer RF, and Albuquerque EX: End plate degeneration in organophosphate (Phosmet) poisoning. Amer. Acad. Neurol., 42nd Annual Meeting, May 4, 1990. Neurology 40 (Suppl. 1):431, 1990.

51. Vriesendorp FJ, Rudnicki S, Koski CL, and Mayer RF: Electrophysiologic studies in Guillain-Barre syndrome (GBS): Effects of plasma exchange. Proceedings of the Peripheral Nerve Association of America, Oxford, England, August 15, 1990.

52. Mayer RF, Good JL, Khurana RK, and Albuquerque EX: Electrophysiologic studies in the intermediate syndrome of organophosphate (OP) poisoning. J. Neurol. Sci. 98 (Suppl):290-291, 1990. VIIth International Congress on Neuromuscular Diseases, September 16-22, 1990, Munich, Germany.

53. Dwyer B and Mayer RF: Long-term azathioprine in the management of refracting myasthenia gravis. Ann. Neurol. 28:240-241, 1990. American Neurological Association, Atlanta, GA, October 14-17, 1990.

54. Wilensky R, Dwyer B, and Mayer RF: Relapses in patients with myasthenia gravis treated with azathioprine. Presented at New York Acad. Sci., Myasthenia gravis and related disorders; experimental and clinical aspects. Washington, D.C., April 12-15, 1992.

55. Mano Y, Tamura R, Takayanagi T, and Mayer RF: Physiologic effects of 3,4-

diaminopyridine in demyelinating peripheral neuropathies. Neurology (Suppl. 2):A323, 1993.

-14-

56. Mayer RF: Advances in the therapy of neuromuscular disease. J. Jap. Assn. Neurol. Ther., May, 1993.

57. Mano Y, Morita Y, Tamura R, Takayanagi T, and Mayer RF: The site of action of magnetic stimulation of human motor cortex. Electroenceph. Clin. Neurophysiol. 87:S36, 1993.

58. Mayer RF, Mano Y, Tamura R, and Takayanagi T: Electrophysiologic effects of 3.4-diaminopyridine in peripheral neuropathies with conduction block. Electroenceph. Clin. Neurophysiol. 87:S65, 1993.

59. Vriesendorp FJ, Triggs WJ, Mayer RF, and Koski CL: Nerve conduction studies in three patients with fulminant Guillain-Barre syndrome and poor recovery. Muscle & Nerve 16:1106, 1993.

60. Mayer RF, Koski CL, and Mano Y: Therapeutic strategies in chronic inflammatory demyelinating polyneuropathy. Muscle & Nerve, Suppl. 1:S236, 1994.

61. Mayer RF: The motor unit, electromyography and neuromuscular diseases. The Xth International Congress of EMG and Clinical Neurophysiology, Exc. Med. Int. Cong. Series 1101, Elsevier, Amsterdam, 97:S29, 1995.

62. Mano Y, Takayanagi T, and Mayer RF: Cortical mapping of skeletal muscles of motor neuron disease. The Xth International Congress of EMG and Clinical Neurophysiology, Exc. Med. Int. Cong. Series 1101, Elsevier, Amsterdam, 97:S27, 1995.

63. Mayer RF and Porter NC: Sixty years of clinical electromyography and the motor unit: The legacy of Derek Denny-Brown, Neurology, 50, Suppl. 4, A121, 1998.

64. Mayer RF: Seventy years of recording the motor unit twitch and action potential: The legacy of Derek Denny-Brown. Clin. Neurophysiol. 110 Suppl. 1:S92, 1999.

PRESENTATIONS: 1987-Present

1. Mayer RF: Studies on the effects of 4-aminopyridine on nerve conduction block. The London Hospital, London, England, March 9, 1987.

2. Mayer RF: Experimental studies on focal demyelinating neuropathies. Neurology Department, Walton Hospital, The University of Liverpool, Liverpool, England, March 13, 1987.

3. Mayer RF and Toyoshima E: Contractile properties of motor units in human neuromuscular disease. Int. Symp. on Motor Units, Mainz, W. Germany, May 18-19, 1987.

4. Mayer RF: Chairman "Neuropathies III" 8th International Congress on Electromyography and Related Clinical Neurophysiology, Sorrento, Italy, May 26, 1987.

5. Mayer RF: Polyneuropathy: Differential diagnosis and management. Physician Memorial Hospital, La Plata, MD, April 14, 1987.

6. Mayer RF: Parkinson's Disease: Diagnosis and treatment. Eastern Shore State Hospital, Cambridge, MD, December 15, 1987.

7. Mayer RF: Living with ALS Symposium: Psychosocial well-being in muscular dystrophy and allied diseases III - Perspectives of the future. Columbia-Presbyterian Medial Center, New York City, January 28-30, 1988.

-15-

8. Mayer RF: Muscle disease: Cramps and weakness. Harford Memorial Hospital, Havre de Grace, MD, February 10, 1988.

9. Mayer RF: Mechanisms and treatment of focal nerve conduction block. Georgetown University Hospital, February 17, 1988.

10. Hsueh I-H, Rudnicki S, and Mayer RF: The effects of psychosine on normal and demyelinated peripheral nerve. American Academy of Neurology, Cincinnati, OH, April 27, 1988.

11. Mayer RF: Studies of conduction block in man and animal. University School of Medicine, Charleston, SC, June 10, 1988.

12. Mayer RF and Hsueh I-H: Treatment of tellurium induced focal nerve conduction block with 4-aminopyridine (4AP). 4th Int. Peripheral Neuropathy Assn., Halifax, N.S., Canada, July 20, 1988.

13. Mayer RF, Hsueh I-H, and Rudnicki S: The effects of intraneural psychosine on peripheral nerve. Soc. Exp. Neuropath., Philadelphia, PA, October 1, 1988.

14. Rudnicki S, Mayer RF, and Koski CL: Electrophysiological correlations with anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome. Amer. Neurol. Assn., Philadelphia, PA, October 5, 1988.

15. Rudnicki S, Mayer RF, and Koski CL: Serial peripheral nerve conduction studies and anti-peripheral nerve myelin antibodies in acute and prolonged Guillain-Barre syndrome. Assoc. Amer. Electromyography and Electrodiagnosis, San Diego, CA, October 7, 1988.

16. Mayer RF: Fatigability and weakness in the elderly: Differential diagnosis and management. Union Hospital, Elkton, MD, November 1, 1988.

17. Mayer RF: Recent advances in muscular dystrophy. Washington County Hospital, Hagerstown, MD, March 2, 1989.

18. Mayer RF: Entrapment neuropathies. Symposium on Practical Neurology for the Primary Care Physician, Saint Joseph Hospital, Towson, MD, March 11, 1989.

19. Mayer RF: Muscle disease. AMI Doctors Hospital, Prince George's County, MD, March 30, 1989.

20. Mayer RF: Physiological studies in acute demyelinating polyneuropathy. Neurological Unit, Boston City Hospital, Boston, MA, March 31, 1989.

21. Mayer RF: Movement disorders. Tremors and tics. Eastern Shore Hospital Center, MD, April 12, 1989.

22. Vriesendorp FJ, Mayer RF, and Koski CL: Plasma exchange and antibody rebound in the Guillain-Barre syndrome. Amer. Acad. Neurol., Chicago, IL, April 17, 1989.

23. Mayer RF: Neurology and music, Electrical Diagnostics, Baltimore, MD, November 1, 1989.

24. Mayer RF: Aches and Pains, The role of the neurologist, Harford Memorial Hospital, Havre de Grace, MD, November 22, 1989.

25. Mayer RF: Parkinson's Disease, AMI Doctors Hospital, Lanham, MD, June 28,

1990.

-16-

26. Mayer RF, Good JL, Khurana RK, and Albuquerque EX: Electrophysiologic studies in the intermediate syndrome of organophosphate (OP) poisoning. VII Inter. Cong. Neuromuscular Diseases, Munich, Germany, September 16-22, 1990.

27. Dwyer B and Mayer RF: Long-term azathioprine in the management of refractory myasthenia gravis. Amer. Neurol. Assn. Meeting, Atlanta, GA, October 17, 1990.

28. Mayer RF: Diagnosis and treatment of myasthenia gravis. Dept. of Neurology, Hahnemann Medical University, Philadelphia, PA, November 16, 1990.

29. Mayer RF: Movement disorders, tremors and tics. Eastern Shore Hospital, Cambridge, MD, May 8, 1991.

30. Mayer RF: Lecturer in Neurology, Visiting Professor, Medical University of Nara, Kyoto, Medical School, Aichi Medical School, National Institute of Neurology, Japan, June, 1991.

31. Mayer RF: Myasthenia gravis. Union Memorial Hospital, Baltimore, MD, October 24, 1991.

32. Mayer RF: Motor units and muscle pathology. Dept. of Neurology, Hahnemann Medical University, Philadelphia, PA, October 25, 1991.

33. Mayer RF: Pre- and post-synaptic autoimmune syndrome. In the Clinical Neuroimmunology Symposium, Baltimore, MD, November 15, 1991.

34. Mayer RF: Polyneuropathies and neuromuscular disorders in endocrine disease. International Symposium on Neuroendocrinology, Bogota, Columbia, March 19-21, 1992.

35. Mayer RF: Pathophysiology of peripheral nerve demyelinating disease. Nara Medical University, Nara, Japan, April 25, 1992.

36. Mayer RF: Diagnosis and management of neuromuscular disease. Neurological Society R.O.C. (Taiwan), Taipei, Taiwan, May 7, 1992.

37. Mayer RF: Neuromuscular disease: A review. Harford Memorial Hospital, Havre de Grace, MD, May 27, 1992.

38. Mayer RF: Weakness and fatiguability in the elderly. Medical Staff, Waynesboro, PA, July 20, 1992.

39. Mayer RF: Pathology of muscle disease. Neurological Unit, Boston City Hospital, Boston, MA, November 13, 1992.

40. Mayer RF: Electrophysiologic studies in conduction block and the Guillain-Barre syndrome. Effects of K+ channel blockers. Neurology Service, NINDS, Bethesda, MD, April 2, 1993.

41. Mayer RF: Immunotherapy in neuromuscular diseases. Department of Neurology, Nara Medical University, Nara, Japan, May 25, 1993.

42. Mayer RF: Restorative therapy in human inflammatory polyneuropathies. Role of K+ channel blockers. East Coast Neuropathy Group, Baltimore, MD, March 23, 1994.

43. Mayer RF: Post polio syndrome. Washington County Hospital, Hagerstown,

MD, March 24, 1994.

-17-

44. Mayer RF: Therapeutic strategies in chronic polyneuropathy. Peripheral Nerve Society Meeting, St. Paul, MN, June 16, 1994.

45. Mayer RF: Therapeutic strategies in chronic inflammatory demyelinating polyneuropathy. VIII Int. Cong. Neuromuscular Diseases, Kyoto, Japan, July 14, 1994.

46. Mayer RF: Update on peripheral nerve disease. Nara Medical University, Nara, Japan, July 21, 1994.

47. Mayer RF: The motor unit, electromyography and neuromuscular diseases. The Xth International Congress of EMG and Clinical Neurophysiology, Kyoto, Japan, October 16, 1995.

48. Mayer RF and Skopets IA: Inclusion body myositis and rimmed vacuole myopathies. International Symposium, Japanese Society for Neuroimmunology, Tokyo, Japan, January 30-31, 1997.

49. Mayer RF: Course on: Magnetic cortical and spinal cord stimulation. XVI World Congress of Neurology, Buenos Aires, Argentina, Co-chairman with Dr. P. Rossini, Rome, Italy, by invitation, September 14, 1997.

50. Mayer RF: Diseases of Muscle. Nara Medical University, Nara, Japan, April 2, 1998.

51. Mayer RF: Peripheral neuropathies: Diagnosis and management. Hokkaido University, Sapporo, Japan, April 16, 1998.

52. Mayer RF and Porter NC, Sixty years of clinical electromyography and the motor unit. The legacy of Derek Denny-Brown. American Academy of Neurology, Annual meeting, Minneapolis, MN, April 28, 1998.

53. Mayer RF: Pathophysiology of the motor unit. Pre-Congress Symposium, Hokkaido University, Sapporo, Japan, June 25, 2000.

LECTURES - MEETINGS (1990-1994)

1. Visiting Professor, University of Alabama at Birmingham, Lecture and rounds. Lecture: Conduction block and demyelinating neuropathies, February 13-14, 1990.

2. Research Conference, Ohio State University, College of Medicine, Department of Neurology, March 30, 1990. Conference: Correlations of electrophysiologic studies and A-PNM Ab titers in GBS: Effect of plasma exchange and Ab rebound.

3. Teaching Conference: Neurologic Unit, Boston City Hospital Research Seminar, Massachusetts General Hospital, Boston, MA, April 5-6, 1990. Conference: Clinical-pathological correlations in muscle disease.

4. New York Academy of Science: Myelination and dysmyelination. Arlington, VA, November 18, 1989.

5. Neural Prosthesis Meeting, NIH, Bethesda, MD, October 18-19, 1989.

6. Association for Research in Nervous and Mental Diseases, New York City, December 1, 1989.

7. International Congress on Movement Disorders, Washington, D.C., April 25-27, 1990.

8. American Association for Electromyography and Electrodiagnosis, Washington, D.C., September 15-16, 1989.

-18-

9. American Neurological Association, New Orleans, LA, September 24-27, 1989.

10. Myasthenia Gravis Medical Advisory Board Meeting, New York City, December 1, 1989.

11. Decade of the Brain Symposium, National Academy of Science, Washington, D.C., July 18-19, 1990.

12. American Neurological Association, Seattle, WA, September 29 - October 2, 1991.

13. Society for Experimental Neuropathology, Seattle, WA, September 28, 1991.

14. Annual Neuroprosthesis Meeting, NIH, Bethesda, MD, October 23, 1991.

15. Association for Research of Nervous and Mental Disorders and the Myasthenia Gravis Medical Advisory Board Meeting, December 6, 1991.

16. New York Academy of Science Meeting on Myasthenia Gravis, Washington, D.C., April 12-15, 1992.

17. American Academy of Neurology, New York City, April 25 - May 1, 1993. Abstract presentation.

18. Japanese Association of Neurologic Therapy, Nara City, Japan, May 12, 1993. Lecture: Advances in the therapy of neuromuscular disease.

19. XIIIth International Congress of Electroencephalography and Clinical Neurophysiology. Vancouver, Canada, August 29 - September 4, 1993. Abstract presentation.

20. 24th Neural Prosthesis Workshop, NINDS, Bethesda, MD, October 13-15, 1993.

21. American Neurological Association, Boston, MA, October 18-20, 1993.

22. Association for Research in Nervous and Mental Disease. New York City, December 1-2, 1993.

23. New York Academy of Sciences, Post-Polio Syndrome. Bethesda, MD, April 27-30, 1994.

24. American Academy of Neurology, Annual Meeting, Washington, D.C., May 2-6, 1994.

25. Peripheral Nerve Society, St. Paul, MN, June 12-16, 1994.

26. VIII International Congress on Neuromuscular Diseases, Kyoto, Japan, July 10-15, 1994.

27. American Neurological Association, 119th Annual Meeting, San Francisco, CA, October 9-12, 1994.

28. Medical Advisory Board Meeting: Myasthenia Gravis Foundation, CMT Foundation, October 8, 1994.

29. Society for Experimental Neuropathology, Annual Meeting, October 8-9, 1994.

30. Association for Research in Nervous and Mental Disease, New York City,

December 2-3, 1994.

BOOK REVIEWS

1. Mayer, R.F.: Atlas of Electromyography. By A. Arturo Leis and Vincent C. Traponi. Ann Nernol. 48:821, 2001.

2. Mayer, R.F.: Psychiatric Management in Neurological Disease. By Edward C. Lauterbach. J Nerv Ment Dis 189:67-68, 2001.

-19-

3. Mayer, R.F.: Frontal-Subcortical Circuits in Psychiatric and Neurological Disorders. By David G. Lichter and Jeffery L. Cummings. J Nerv Ment Dis. 190:202-203, 2002.

4. Mayer, R.F.: Origins of Neuroscience. By Stanley Finger. J. Nerv Ment Dis. 190:568-569, 2002.

LETTERS TO EDITOR

1. Mayer, R.F.: Neurology Was There: 1929. Arch Neurol. 58:1024,2001.

FELLOWS - CLINICAL NEUROPHYSIOLOGY AND NEUROMUSCULAR DISEASE

1. Clifford Mawdsley, M.D., Research Fellow (1963-1964) (Deceased)

2. Palle Juul-Jensen, M.D., Research Fellow (1965-1966)

3. Robert G. Feldman, M.D., Clinical Fellow (1964-1965)

4. Ricardo Garcia-Mullin, M.D., Research Fellow (1967-1970)

5. Frank Kemble, M.D., Clinical Fellow (1969-1970)

6. Ira Wexler, M.D., Research Fellow (1971-1972)

7. Carol Lee Koski, M.D., Research Fellow (1971-1972)

8. Ian R. Williams, M.D., Research Fellow (1972-1973)

9. Yukio Mano, M.D., Research Fellow (1973-1974)

10. Joseph L. Young, Ph.D., Research Fellow (1976-1979)

11. James Toop, Ph.D., Research Fellow, NIH (1976-1979)

12. Richard Tomasulo, M.D., Clinical Fellow (1978-1979)

13. Mostafa Sadry, M.D., Clinical Fellow (1979-1980)

14. Roger Weiss, M.D., Clinical Fellow (1980-1981)

15. Michael Sellman, M.D., Clinical Fellow (1980-1981)

16. Richard Peters, M.D., Clinical Fellow (1981-1982)

17. Stephen Yeagle, Ph.D., Research Fellow (1981-1982)

18. Scott Cherry, M.D., Clinical Fellow (1982-1983)

19. Praful Dave, M.D., Clinical Fellow (1983-1984)

20. Ernesto Potes, M.D., Clinical Fellow (1984-1985)

21. Eitoku Toyoshima, Ph.D., Research Fellow (1982-1986)

22. Anastasio DeCastro, M.D., Clinical Fellow (1985-1986)

23. Stacy Rudnicki, M.D., Clinical Fellow (1986-1987)

-20-

24. Edward Spellman, M.D., Clinical Fellow (1987-1988)

25. I-H Hsueh, M.D., Research Fellow (1986-1987)

26. Francine Vriesendorp, M.D., Clinical Fellow (1987-1988)

27. R. Kishore Kumar, M.D., Clinical Fellow (1988-1989)

28. Janine Good, M.D., Clinical Fellow (1989-1990)

29. Boyd Dwyer, M.D., Clinical Fellow (1990-1991)

30. Raymon Wilensky, M.D., Clinical Fellow (1991-1992)

31. David Hart, M.D., Clinical Fellow (1992-1993)

32. B. Joan Oshinsky, M.D., Ph.D., Clinical Fellow (1993-1994)

33. Neil Porter, M.D., Clinical Fellow (1994-1995)

34. Michael Weiss, M.D., Clinical Fellow (1995-1996)

35. Irina Skopets, M.D., Clinical Fellow (1996-1997)

-21-